Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease
Sponsor: University Hospital, Toulouse
Summary
This study will be conducted in three parallel groups receiving oxycodone, levodopa or placebo, administered as an add-on therapy, in addition to the usual antiparkinsonian treatment. As this study focuses on chronic central neuropathic pain caused by PD, the effects of study treatments will be evaluated after a 10-week treatment period
Official title: Evaluation of the Analgesic Effects of Prolonged-release Oxycodone and of Levodopa, Versus Placebo, on Central Neuropathic Pain in Parkinson's Disease: OXYDOPA Trial
Key Details
Gender
All
Age Range
40 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
67
Start Date
2016-09
Completion Date
2020-11
Last Updated
2026-05-04
Healthy Volunteers
No
Conditions
Interventions
PR Oxycodone
PR Oxycodone
Levodopa
Levodopa
Oxycodone Placebo
Placebo of PR Oxycodone
Levodopa placebo
Locations (18)
Hospital of Aix-en-Provence
Aix-en-Provence, France
CHU Amiens
Amiens, France
University Hospital of Bordeaux
Bordeaux, France
University Hospital of Clermont-Ferrand
Clermont-Ferrand, France
Henri Mondor Hospital
Créteil, France
University Hospital of Lille
Lille, France
University Hospital of Limoges
Limoges, France
Hospital Pierre Wertheimer
Lyon, France
University Hospital of Marseille
Marseille, France
University Hospital of Nancy
Nancy, France
University Hospital of Nantes
Nantes, France
University Hospital of Nîmes - Caremeau
Nîmes, France
Pitié-Salpêtrière Hospital
Paris, France
University Hospital of Poitiers
Poitiers, France
University Hospital of Rennes
Rennes, France
University Hospital of Rouen
Rouen, France
University Hospital of Strasbourg
Strasbourg, France
Chu Toulouse
Toulouse, France